Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,553 | 67,975 | -54,451 | -34,380 | -81,723 |
| Depreciation Amortization | 6,467 | 5,508 | 5,082 | 4,647 | 3,492 |
| Accounts receivable | -184 | -334 | -260 | 7 | -75 |
| Accounts payable and accrued liabilities | -821 | 4,844 | -1,270 | -3,510 | 2,555 |
| Other Working Capital | -61,078 | 87,159 | -5,878 | -1,207 | 5,718 |
| Other Operating Activity | 44,368 | 7,883 | 9,553 | 10,504 | 5,605 |
| Operating Cash Flow | $-95,801 | $173,035 | $-47,223 | $-23,939 | $-64,428 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -278,964 | -35,745 | -6,014 | -40,726 | 17,308 |
| PPE Investments | -11,952 | -12,001 | -1,421 | -7,918 | -3,860 |
| Sale Of Investment | 50,138 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-240,778 | $-47,746 | $-7,435 | $-48,644 | $13,448 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,415 | -209 | -198 | -218 |
| Common Stock Issued | 257,948 | 68,797 | 60,216 | 12,692 | 55,984 |
| Other Financing Activity | 0 | 0 | -55 | -439 | -634 |
| Financing Cash Flow | $257,948 | $66,382 | $59,953 | $12,055 | $55,132 |
| Exchange Rate Effect | 410 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 221,804 | 30,133 | 24,839 | 85,367 | 81,214 |
| End Cash Position | 143,583 | 221,804 | 30,133 | 24,839 | 85,367 |
| Net Cash Flow | $-78,221 | $191,671 | $5,295 | $-60,528 | $4,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -95,801 | 173,035 | -47,223 | -23,939 | -64,428 |
| Capital Expenditure | -11,952 | -12,001 | -1,421 | -7,918 | -3,860 |
| Free Cash Flow | -107,753 | 161,034 | -48,645 | -31,857 | -68,288 |